1. Home
  2. MIST vs LSE Comparison

MIST vs LSE Comparison

Compare MIST & LSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • LSE
  • Stock Information
  • Founded
  • MIST 2003
  • LSE 2007
  • Country
  • MIST Canada
  • LSE China
  • Employees
  • MIST N/A
  • LSE N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • LSE Metal Fabrications
  • Sector
  • MIST Health Care
  • LSE Industrials
  • Exchange
  • MIST Nasdaq
  • LSE Nasdaq
  • Market Cap
  • MIST 89.8M
  • LSE 85.6M
  • IPO Year
  • MIST N/A
  • LSE 2024
  • Fundamental
  • Price
  • MIST $1.60
  • LSE $5.76
  • Analyst Decision
  • MIST Strong Buy
  • LSE
  • Analyst Count
  • MIST 2
  • LSE 0
  • Target Price
  • MIST $7.50
  • LSE N/A
  • AVG Volume (30 Days)
  • MIST 1.8M
  • LSE 1.4M
  • Earning Date
  • MIST 08-07-2025
  • LSE 01-01-0001
  • Dividend Yield
  • MIST N/A
  • LSE N/A
  • EPS Growth
  • MIST N/A
  • LSE N/A
  • EPS
  • MIST N/A
  • LSE 0.52
  • Revenue
  • MIST N/A
  • LSE $69,073,374.00
  • Revenue This Year
  • MIST N/A
  • LSE N/A
  • Revenue Next Year
  • MIST N/A
  • LSE N/A
  • P/E Ratio
  • MIST N/A
  • LSE $10.97
  • Revenue Growth
  • MIST N/A
  • LSE N/A
  • 52 Week Low
  • MIST $0.63
  • LSE $3.76
  • 52 Week High
  • MIST $2.75
  • LSE $14.99
  • Technical
  • Relative Strength Index (RSI)
  • MIST 83.15
  • LSE N/A
  • Support Level
  • MIST $1.86
  • LSE N/A
  • Resistance Level
  • MIST $1.97
  • LSE N/A
  • Average True Range (ATR)
  • MIST 0.14
  • LSE 0.00
  • MACD
  • MIST 0.06
  • LSE 0.00
  • Stochastic Oscillator
  • MIST 100.00
  • LSE 0.00

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment which supplies various equipments, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

Share on Social Networks: